Left ventricular non-compaction associated with a genetic variant of the CYP2C9 gene
- PMID: 16580879
- DOI: 10.1016/j.hlc.2006.02.007
Left ventricular non-compaction associated with a genetic variant of the CYP2C9 gene
Abstract
Polymorphisms in the CYP2C9 gene can have a significant impact on drug therapy by affecting the pharmacokinetics of frequently prescribed drugs, such as phenprocoumon and warfarin. It is essential therefore that genetic CYP2C9 variants are excluded in patients with a suspected intolerance of anticoagulant therapy. Here we present the first report of a case of left ventricular non-compaction syndrome associated with a genetic variant of the CYP2C9 gene in a 45-year-old woman with myocardial insufficiency who was scheduled for implantation of a cardioverter defibrillator.
Comment in
-
Non-indicated oral anticoagulation in left ventricular hypertrabeculation/noncompaction may jeopardize these patients.Heart Lung Circ. 2006 Dec;15(6):402; author reply 403. doi: 10.1016/j.hlc.2006.07.001. Epub 2006 Oct 10. Heart Lung Circ. 2006. PMID: 17035083 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
